Updates on the preoperative immunotherapy for triple-negative breast cancer

Transl Breast Cancer Res. 2023 Apr 30:4:17. doi: 10.21037/tbcr-23-16. eCollection 2023.

Authors

Hong Hu¹, Virginia Kaklamani²

Affiliations

¹ Division of Breast Surgery, Department of General Surgery, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
² Division of Hematology/Oncology, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, USA.

No abstract available

Keywords: Triple negative breast cancer (TNBC); immunotherapy; neoadjuvant; pembrolizumab.

Publication types

Editorial